<DOC>
	<DOCNO>NCT00004102</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . Leucovorin may increase effectiveness fluorouracil make tumor cell sensitive drug . PURPOSE : Phase II trial study effectiveness combination chemotherapy consist oxaliplatin , fluorouracil , leucovorin treat patient colorectal cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Advanced Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate quantitative qualitative toxicity oxaliplatin combine fluorouracil leucovorin calcium patient advance adenocarcinoma colon rectum . OUTLINE : Patients receive leucovorin calcium IV 10-20 minute follow within 10 minute fluorouracil IV bolus day 1 , 8 , 15 , 29 , 36 , 43 . Patients receive oxaliplatin IV 2 hour prior leucovorin calcium fluorouracil day 1 , 15 , 29 , 43 . Treatment repeat every 8 week 3 course absence disease progression unacceptable toxicity . Patients stable respond disease may receive additional course upon approval sponsor . Patients follow 30 day . PROJECTED ACCRUAL : A total 18-35 patient accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven advanced adenocarcinoma colon rectum No prior systemic chemotherapy OR Adjuvant chemotherapy , complete 6 month prior study subsequent development recurrent disease At least 1 bidimensionally measurable lesion No CNS metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Greater 12 week Hematopoietic : Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 2.0 mg/dL ( great 5.0 mg/dL due intrahepatic biliary obstruction amenable biliary decompression , approve protocol investigator ) SGOT great 4 time upper limit normal Renal : Creatinine great 1.5 mg/dL Cardiovascular : No myocardial infarction within past 6 month No congestive heart failure Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No neurologic disease No active uncontrolled infection No malignancy within past 5 year except nonmelanomatous skin cancer carcinoma situ cervix No medical psychiatric disorder would prevent compliance PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy malignant disease Surgery : Recovered prior surgery Other : At least 30 day since prior investigational agent No concurrent investigational agent No concurrent anticancer agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
</DOC>